Lilian Wikström
Mercer University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Lilian Wikström.
Journal of Neuroscience Research | 2008
Göran Bertilsson; Olof Zachrisson; Annica Andersson; Karin Dannaeus; Jessica Heidrich; Jarkko Kortesmaa; Alex Mercer; Elisabet Nielsen; Harriet Rönnholm; Lilian Wikström
We investigated the effects of exendin‐4 on neural stem/progenitor cells in the subventricular zone of the adult rodent brain and its functional effects in an animal model of Parkinsons disease. Our results showed expression of GLP‐1 receptor mRNA or protein in the subventricular zone and cultured neural stem/progenitor cells isolated from this region. In vitro, exendin‐4 increased the number of neural stem/progenitor cells, and the number of cells expressing the neuronal markers microtubule‐associated protein 2, β‐III‐tubulin, and neuron‐specific enolase. When exendin‐4 was given intraperitoneally to naïve rodents together with bromodeoxyuridine, a marker for DNA synthesis, both the number of bromodeoxyuridine‐positive cells and the number of neuronal precursor cells expressing doublecortin were increased. Exendin‐4 was tested in the 6‐hydroxydopamine model of Parkinsons disease to investigate its possible functional effects in an animal model with neuronal loss. After unilateral lesion and a 5‐week stabilization period, the rats were treated for 3 weeks with exendin‐4. We found a reduction of amphetamine‐induced rotations in animals receiving exendin‐4 that persisted for several weeks after drug administration had been terminated. Histological analysis showed that exendin‐4 significantly increased the number of both tyrosine hydroxylase‐ and vesicular monoamine transporter 2‐positive neurons in the substantia nigra. In conclusion, our results show that exendin‐4 is able to promote adult neurogenesis in vitro and in vivo, normalize dopamine imbalance, and increase the number of cells positive for markers of dopaminergic neurons in the substantia nigra in a model of Parkinsons disease.
European Journal of Pharmacology | 2011
Ruben Isacson; Elisabet Nielsen; Karin Dannaeus; Göran Bertilsson; Olof Zachrisson; Lilian Wikström
We have earlier shown that the glucagon-like peptide 1 receptor agonist exendin-4 stimulates neurogenesis in the subventricular zone and excerts anti-parkinsonian behavior. The aim of this study was to assess the effects of exendin-4 treatment on hippocampus-associated cognitive and mood-related behavior in adult rodents. To investigate potential effects of exendin-4 on hippocampal function, radial maze and forced swim test were employed. The time necessary to solve a radial maze task and the duration of immobility in the forced swim test were significantly reduced compared to respective vehicle groups if the animals had received exendin-4 during 1-2weeks before testing. In contrast to the positive control imipramine, single administration of exendin-4 1h before the challenge in the forced swim test had no effect. Immunohistochemical analysis showed that the incorporation of bromodeoxyuridine, a marker for DNA synthesis, as well as doublecortin expression was increased in the hippocampal dentate gyrus following chronic treatment with exendin-4 compared to vehicle-treated controls. The neurogenic effect of exendin-4 on hippocampus was confirmed by quantitative PCR showing an upregulation of mRNA expression for Ki-67, doublecortin and Mash-1. Since exendin-4 significantly improves hippocampus-associated behavior in adult rodents, it may be a candidate for alleviation of mood and cognitive disorders.
Journal of Parkinson's disease | 2011
Olof Zachrisson; Zhao M; Andersson A; Karin Dannaeus; Häggblad J; Isacson R; Elisabet Nielsen; Harriet Rönnholm; Lilian Wikström; Delfani K; McCormack Al; Palmer T; Di Monte Da; Hill Mp; Janson Lang Am; Haegerstrand A
Parkinsons disease is characterized by motor deficits caused by loss of midbrain dopaminergic neurons. Neurotrophic factors and cell transplantation have partially restored function in models of Parkinsons disease, but have had limited effects in humans. Here we show that intracerebroventricular administration of platelet-derived growth factor-BB can offer an alternative strategy to restore function in Parkinsons disease; In animal models of nigrostriatal injury, a two weeks treatment with platelet-derived growth factor-BB resulted in long-lasting restoration of striatal dopamine transporter binding sites and expression of nigral tyrosine hydroxylase. It also normalized amphetamine-induced rotational behavior in 6-hydroxydopamine lesioned rats. Platelet-derived growth factor-BB promoted proliferation of neural progenitor cells in the subventricular zone. The effects on dopaminergic neurons and functional recovery could be blocked by co-infusion with a proliferation inhibitor, indicating a link between the proliferative and anti-parkinsonian effects. Based on the current data, we consider platelet-derived growth factor-BB a clinical candidate drug for treatment of Parkinsons disease.
BMC Neuroscience | 2005
Maria Sievertzon; Valtteri Wirta; Alex Mercer; Konstantinos Meletis; Lilian Wikström; Jonas Frisén; Joakim Lundeberg
BackgroundNeural stem cells (NSCs) can be isolated from the adult mammalian brain and expanded in culture, in the form of cellular aggregates called neurospheres. Neurospheres provide an in vitro model for studying NSC behaviour and give information on the factors and mechanisms that govern their proliferation and differentiation. They are also a promising source for cell replacement therapies of the central nervous system. Neurospheres are complex structures consisting of several cell types of varying degrees of differentiation. One way of characterising neurospheres is to analyse their gene expression profiles. The value of such studies is however uncertain since they are heterogeneous structures and different populations of neurospheres may vary significantly in their gene expression.ResultsTo address this issue, we have used cDNA microarrays and a recently reported tag cDNA amplification method to analyse the gene expression profiles of neurospheres originating from separate isolations of the lateral ventricle wall of adult mice and passaged to varying degrees. Separate isolations as well as consecutive passages yield a high variability in gene expression while parallel cultures yield the lowest variability.ConclusionsWe demonstrate a low technical amplification variability using the employed amplification strategy and conclude that neurospheres from the same isolation and passage are sufficiently similar to be used for comparative gene expression analysis.
Archive | 2003
Göran Bertilsson; Rikard Erlandsson; Jonas Frisen; Anders Haegerstrand; Jessica Heidrich; Nina Hellstrom; Johan Haggblad; Katarina Jansson; Jarkko Kortesmaa; Per Lindquist; Jacqueline Mcguire; Alex Mercer; Karl Nyberg; Amina Ossoinak; Cesare Patrone; Harriet Rönnholm; Lilian Wikström; Olof Zachrisson
Archive | 2007
Per Lindquist; Alex Mercer; Harriet Ronnholm; Lilian Wikström
Archive | 2003
Alex Mercer; Cesare Patrone; Harriet Rönnholm; Lilian Wikström
Archive | 2002
Göran Bertilsson; Anna Falk; Jonas Frisen; Jessica Heidrich; Kristina Hellström; Jarkko Kortesmaa; Per Lindquist; Jacqueline Mcguire; Alex Mercer; Cesare Patrone; Harriet Rönnholm; Lilian Wikström; Olof Zachrisson
Experimental Cell Research | 2006
Cecilia Williams; Valtteri Wirta; Konstantinos Meletis; Lilian Wikström; Leif Carlsson; Jonas Frisén; Joakim Lundeberg
Archive | 2007
Per Lindquist; Göran Bertilsson; Alex Mercer; Cesare Patrone; Lilian Wikström; Olof Zachrisson